-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Parkinson's disease (PD) is one of the most common neurodegenerative diseases, characterized by bradykinesia, resting tremor, stiffness, and postural instability
.
Although dopaminergic drugs are the main drugs to relieve the symptoms of Parkinson's disease, there is a lack of effective disease correction treatment
Parkinson's disease (PD) is one of the most common neurodegenerative diseases, characterized by bradykinesia, resting tremor, stiffness, and postural instability
Life>
Some studies have studied the relationship between PA and PD progression
This cohort study based on a national population used data from the Korean National Medical Insurance System
.
Participants underwent a follow-up survey from January 1, 2010 to December 31, 2013, until December 31, 2017
This cohort study based on a national population used data from the Korean National Medical Insurance System
The level of physical activity was collected using a self-filled questionnaire
- A total of 45,923 people were confirmed; 10,987 people were registered, 34 people under the age of 40 and 254 people with missing data were excluded
.
A total of 10699 patients with Parkinson's disease were enrolled, including 4925 males (46%) and 5774 females (54%), with an average age of 69.
This analysis found a dose-response relationship between PA and Parkinson’s disease all-cause mortality
Literature source: https://jamanetwork-com.
fjny.
80599.
net/journals/jamaneurology/article-abstract/2785851 https://jamanetwork-com.
fjny.
80599.
net/journals/jamaneurology/article-abstract/2785851 in This message